Scios Natrecor Outcomes Study Is Expected To Begin Enrollment In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
The Johnson & Johnson subsidiary will begin enrollment more than a year after an independent panel recommended the study.
You may also be interested in...
American Heart Association Research, In Brief
Outcomes Study Resuscitates Natrecor
American Heart Association Research, In Brief
Outcomes Study Resuscitates Natrecor
Natrecor Concerns Are Limiting Use Of Other IV Vasoactive Therapies As Well, JAMA Finds
Decline in use of other congestive heart failure therapies raises concerns about the effect of articles that question the safety of approved medications.